Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado

Detalhes bibliográficos
Autor(a) principal: Barbalho, Cilene Aparecida
Data de Publicação: 2007
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFSCAR
Texto Completo: https://repositorio.ufscar.br/handle/ufscar/1290
Resumo: Previous studies demonstrated that microinjections of midazolam (MDZ), GABAAbenzodiazepine (BDZs) receptor agonist, into the amygdala (AMY) produce anxiolytic effects in the elevated plus-maze (EPM) naïve-mice. During the reexposured to the EPM is increasing avoidance of open arms and impairs the anxiolytic like effect of BDZs, phenomenon characterized as "one trial tolerance" (OTT). This study investigated the effects of intra-AMY infusions of midazolam (MDZ) in EPM-experienced mice and GABAA-BDZs receptor antagonist, flumazenil (FMZ), intra-AMY, on anxiety in EPM-naïve and EPMexperienced mice. The analysis was performed on conventional measures of anxiety (% open arm entries and % open arm time), locomotor activity (frequency of closed arm entries) and a range of ethological measures related to risk assessment. The intra-AMY infusions of MDZ (3.0 and 30 nmol/0.1µl) increased % open arm entries (%OA) and % open arm time (%OT) in EPM-experienced mice. The analysis of ethological measures demonstrated that MDZ increased the total head dipping (THD) and decreased percent protected head dipping (%PHD) and percent protected stretched attend postures (%PSAP) without any significant change to total stretched attend (TSAP), total rearing (TR) and total immobility (TI). The intra-AMY infusions of FMZ 16 (nmol/0.1µl), increased %OA and %OT in maze-naïve and maze-experienced mice. The analysis of ethological measures reveals that FMZ increased the THD and TSAP and decreased %PHD and %PSAP without any significant change to TSAP, TR and TI in maze-naïve. In EPM-experienced mice, intra-AMY infusions of FMZ only increased TSAP without alter any other ethological measure. Interestingly, combined administration of DMCM (1.0 mg/Kg) and FMZ (2.0 nmol) significantly decreased the %OA and %OT when compared to vehicle+vehicle. The anxiogenic-like effect produced by GABAA receptor inverse agonist was blocked by intra-AMY infusions of FMZ. FMZ plus vehicle produced absence of effects. These effects were observed in the absence of significant changes in locomotor activity, indicating a selective anxiolytic-like effect for MDZ and FMZ. Interestingly, both benzodiazepine receptor agonist and antagonist, MDZ and FLU, respectively, produced selective anxiolytic-like effects when injected into the amygdala in maze-experienced mice. Together, present results demonstrate that GABA-benzodiazepine receptor complex located within the AMY did not involvement in the OTT phenomenon. However, the anxiogenic-like effect produced by GABA-BDZs receptor inverse agonist was blocked by intra-AMY infusions of FMZ. These results suggest that the emotional state induced by plus-maze test someway releases endogenous benzodiazepine receptor inverse agonist within the amygdala.
id SCAR_c60948488b3494839603998223b8bef9
oai_identifier_str oai:repositorio.ufscar.br:ufscar/1290
network_acronym_str SCAR
network_name_str Repositório Institucional da UFSCAR
repository_id_str 4322
spelling Barbalho, Cilene AparecidaSouza, Azair Liane Matos do Canto dehttp://lattes.cnpq.br/2352004564367849http://lattes.cnpq.br/72062853346039867cdea2cc-be4b-4181-8c21-63f540dc6b6f2016-06-02T19:22:48Z2008-03-282016-06-02T19:22:48Z2007-12-17BARBALHO, Cilene Aparecida. Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado. 2007. 93 f. Dissertação (Mestrado em Ciências Biológicas) - Universidade Federal de São Carlos, São Carlos, 2007.https://repositorio.ufscar.br/handle/ufscar/1290Previous studies demonstrated that microinjections of midazolam (MDZ), GABAAbenzodiazepine (BDZs) receptor agonist, into the amygdala (AMY) produce anxiolytic effects in the elevated plus-maze (EPM) naïve-mice. During the reexposured to the EPM is increasing avoidance of open arms and impairs the anxiolytic like effect of BDZs, phenomenon characterized as "one trial tolerance" (OTT). This study investigated the effects of intra-AMY infusions of midazolam (MDZ) in EPM-experienced mice and GABAA-BDZs receptor antagonist, flumazenil (FMZ), intra-AMY, on anxiety in EPM-naïve and EPMexperienced mice. The analysis was performed on conventional measures of anxiety (% open arm entries and % open arm time), locomotor activity (frequency of closed arm entries) and a range of ethological measures related to risk assessment. The intra-AMY infusions of MDZ (3.0 and 30 nmol/0.1µl) increased % open arm entries (%OA) and % open arm time (%OT) in EPM-experienced mice. The analysis of ethological measures demonstrated that MDZ increased the total head dipping (THD) and decreased percent protected head dipping (%PHD) and percent protected stretched attend postures (%PSAP) without any significant change to total stretched attend (TSAP), total rearing (TR) and total immobility (TI). The intra-AMY infusions of FMZ 16 (nmol/0.1µl), increased %OA and %OT in maze-naïve and maze-experienced mice. The analysis of ethological measures reveals that FMZ increased the THD and TSAP and decreased %PHD and %PSAP without any significant change to TSAP, TR and TI in maze-naïve. In EPM-experienced mice, intra-AMY infusions of FMZ only increased TSAP without alter any other ethological measure. Interestingly, combined administration of DMCM (1.0 mg/Kg) and FMZ (2.0 nmol) significantly decreased the %OA and %OT when compared to vehicle+vehicle. The anxiogenic-like effect produced by GABAA receptor inverse agonist was blocked by intra-AMY infusions of FMZ. FMZ plus vehicle produced absence of effects. These effects were observed in the absence of significant changes in locomotor activity, indicating a selective anxiolytic-like effect for MDZ and FMZ. Interestingly, both benzodiazepine receptor agonist and antagonist, MDZ and FLU, respectively, produced selective anxiolytic-like effects when injected into the amygdala in maze-experienced mice. Together, present results demonstrate that GABA-benzodiazepine receptor complex located within the AMY did not involvement in the OTT phenomenon. However, the anxiogenic-like effect produced by GABA-BDZs receptor inverse agonist was blocked by intra-AMY infusions of FMZ. These results suggest that the emotional state induced by plus-maze test someway releases endogenous benzodiazepine receptor inverse agonist within the amygdala.Estudos anteriores têm demonstrado que microinjeções de midazolam (MDZ), agonista GABAA-benzodiazepínico (BDZs), na amígdala (AMG) de camundongos ingênuos produz efeito ansiolítico no labirinto em cruz elevado (LCE). Durante a reexposição ao LCE ocorre aumento da evitação dos braços abertos e a perda do efeito ansiolítico dos BDZs, fenômeno conhecido como one trial tolerance (OTT). Este estudo investigou os efeitos de injeções de MDZ em camundongos reexpostos ao LCE e do antagonista dos receptores GABAA-BDZs, flumazenil (FMZ), intra-AMG, em camundongos ingênuos e reexpostos ao LCE. A possível ação do FMZ em agonistas inversos endógenos foi avaliada com a administração combinada de DMCM em animais ingênuos ao LCE. Foi realizada a análise das medidas convencionais de ansiedade (% entradas e de tempo gasto nos braços abertos do LCE), atividade locomotora (freqüência de entradas nos braços fechados) e medidas etológicas associadas à avaliação de risco. A infusão intra-AMG de MDZ (3,0 e 30 nmol/0,1µl) em camundongos, aumentou a % de entradas e de tempo gasto nos braços abertos após a reexposição ao LCE. Enquanto que as medidas etológicas de avaliação de risco demonstraram que o midazolam aumentou o total de mergulhos e diminuiu a porcentagem de mergulhar e esticar protegido, porém não revelou mudança significativa no total de esticar, levantar e de imobilidade. A infusão intra-AMG de FMZ 16 (nmol/0,1µl), aumentou a % de entradas e de tempo gasto nos braços abertos do LCE, em camundongos ingênuos e reexpostos ao labirinto. A análise das medidas etológicas demonstraram que o FMZ aumentou o total de mergulhos e de esticadas e diminuiu a porcentagem de mergulhar e esticar protegido, sem alterar significativamente o total de esticar, levantar e de imobilidade. A administração combinada de DMCM (1,0 mg/kg) e FMZ (2 nmol/0,1µl)em camundongos ingênuos, significativamente diminuiu as porcentagens de entrada e de tempo gasto nos braços abertos do LCE. O efeito ansiogênico produzido pelo agonista inverso dos receptores GABAA, foi bloqueado pelas microinjeções de FMZ intra-AMG em camundongos ingênuos ao LCE. O FMZ sozinho produziu ausência de efeitos. Os efeitos dos tratamentos com MDZ e FMZ foram observados na ausência de alteração da atividade locomotora. Entretanto, tanto o agonista como o antagonista dos receptores GABAA-BDZs quando administrados na AMG produziram efeito ansiolítico seletivo. Estes resultados sugerem que os receptores GABAABDZs da amígdala não estão envolvidos no processo de modulação do fenômeno OTT. Contudo, o efeito ansiogênico produzido pelo DMCM foi bloqueado pela administração intra- AMG de FMZ. Assim, o estado emocional induzido pela exposição ao LCE parece liberar agonistas inversos benzodiazepínicos na amígdala de camundongos.Financiadora de Estudos e Projetosapplication/pdfporUniversidade Federal de São CarlosPrograma Interinstitucional de Pós-Graduação em Ciências Fisiológicas - PIPGCFUFSCarBRNeurologiaAnsiedadeLabirinto em cruz elevadoCamundongosGABA (Ácido Gama Amino Butírico)Núcleo central da amigdalaCIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::NEUROLOGIAPapel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevadoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis-1-1ec59bf11-8f1b-4d55-a0dd-35037d3bb124info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSCARinstname:Universidade Federal de São Carlos (UFSCAR)instacron:UFSCARORIGINAL1710.pdfapplication/pdf768269https://repositorio.ufscar.br/bitstream/ufscar/1290/1/1710.pdfe782712ebc5089e6011701c6a7756744MD51THUMBNAIL1710.pdf.jpg1710.pdf.jpgIM Thumbnailimage/jpeg6269https://repositorio.ufscar.br/bitstream/ufscar/1290/2/1710.pdf.jpgdf35a859fd82baf004e5de12ff883c81MD52ufscar/12902023-09-18 18:31:52.568oai:repositorio.ufscar.br:ufscar/1290Repositório InstitucionalPUBhttps://repositorio.ufscar.br/oai/requestopendoar:43222023-09-18T18:31:52Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)false
dc.title.por.fl_str_mv Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
title Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
spellingShingle Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
Barbalho, Cilene Aparecida
Neurologia
Ansiedade
Labirinto em cruz elevado
Camundongos
GABA (Ácido Gama Amino Butírico)
Núcleo central da amigdala
CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::NEUROLOGIA
title_short Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
title_full Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
title_fullStr Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
title_full_unstemmed Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
title_sort Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado
author Barbalho, Cilene Aparecida
author_facet Barbalho, Cilene Aparecida
author_role author
dc.contributor.authorlattes.por.fl_str_mv http://lattes.cnpq.br/7206285334603986
dc.contributor.author.fl_str_mv Barbalho, Cilene Aparecida
dc.contributor.advisor1.fl_str_mv Souza, Azair Liane Matos do Canto de
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/2352004564367849
dc.contributor.authorID.fl_str_mv 7cdea2cc-be4b-4181-8c21-63f540dc6b6f
contributor_str_mv Souza, Azair Liane Matos do Canto de
dc.subject.por.fl_str_mv Neurologia
Ansiedade
Labirinto em cruz elevado
Camundongos
GABA (Ácido Gama Amino Butírico)
Núcleo central da amigdala
topic Neurologia
Ansiedade
Labirinto em cruz elevado
Camundongos
GABA (Ácido Gama Amino Butírico)
Núcleo central da amigdala
CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::NEUROLOGIA
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::NEUROLOGIA
description Previous studies demonstrated that microinjections of midazolam (MDZ), GABAAbenzodiazepine (BDZs) receptor agonist, into the amygdala (AMY) produce anxiolytic effects in the elevated plus-maze (EPM) naïve-mice. During the reexposured to the EPM is increasing avoidance of open arms and impairs the anxiolytic like effect of BDZs, phenomenon characterized as "one trial tolerance" (OTT). This study investigated the effects of intra-AMY infusions of midazolam (MDZ) in EPM-experienced mice and GABAA-BDZs receptor antagonist, flumazenil (FMZ), intra-AMY, on anxiety in EPM-naïve and EPMexperienced mice. The analysis was performed on conventional measures of anxiety (% open arm entries and % open arm time), locomotor activity (frequency of closed arm entries) and a range of ethological measures related to risk assessment. The intra-AMY infusions of MDZ (3.0 and 30 nmol/0.1µl) increased % open arm entries (%OA) and % open arm time (%OT) in EPM-experienced mice. The analysis of ethological measures demonstrated that MDZ increased the total head dipping (THD) and decreased percent protected head dipping (%PHD) and percent protected stretched attend postures (%PSAP) without any significant change to total stretched attend (TSAP), total rearing (TR) and total immobility (TI). The intra-AMY infusions of FMZ 16 (nmol/0.1µl), increased %OA and %OT in maze-naïve and maze-experienced mice. The analysis of ethological measures reveals that FMZ increased the THD and TSAP and decreased %PHD and %PSAP without any significant change to TSAP, TR and TI in maze-naïve. In EPM-experienced mice, intra-AMY infusions of FMZ only increased TSAP without alter any other ethological measure. Interestingly, combined administration of DMCM (1.0 mg/Kg) and FMZ (2.0 nmol) significantly decreased the %OA and %OT when compared to vehicle+vehicle. The anxiogenic-like effect produced by GABAA receptor inverse agonist was blocked by intra-AMY infusions of FMZ. FMZ plus vehicle produced absence of effects. These effects were observed in the absence of significant changes in locomotor activity, indicating a selective anxiolytic-like effect for MDZ and FMZ. Interestingly, both benzodiazepine receptor agonist and antagonist, MDZ and FLU, respectively, produced selective anxiolytic-like effects when injected into the amygdala in maze-experienced mice. Together, present results demonstrate that GABA-benzodiazepine receptor complex located within the AMY did not involvement in the OTT phenomenon. However, the anxiogenic-like effect produced by GABA-BDZs receptor inverse agonist was blocked by intra-AMY infusions of FMZ. These results suggest that the emotional state induced by plus-maze test someway releases endogenous benzodiazepine receptor inverse agonist within the amygdala.
publishDate 2007
dc.date.issued.fl_str_mv 2007-12-17
dc.date.available.fl_str_mv 2008-03-28
2016-06-02T19:22:48Z
dc.date.accessioned.fl_str_mv 2016-06-02T19:22:48Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv BARBALHO, Cilene Aparecida. Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado. 2007. 93 f. Dissertação (Mestrado em Ciências Biológicas) - Universidade Federal de São Carlos, São Carlos, 2007.
dc.identifier.uri.fl_str_mv https://repositorio.ufscar.br/handle/ufscar/1290
identifier_str_mv BARBALHO, Cilene Aparecida. Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado. 2007. 93 f. Dissertação (Mestrado em Ciências Biológicas) - Universidade Federal de São Carlos, São Carlos, 2007.
url https://repositorio.ufscar.br/handle/ufscar/1290
dc.language.iso.fl_str_mv por
language por
dc.relation.confidence.fl_str_mv -1
-1
dc.relation.authority.fl_str_mv ec59bf11-8f1b-4d55-a0dd-35037d3bb124
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de São Carlos
dc.publisher.program.fl_str_mv Programa Interinstitucional de Pós-Graduação em Ciências Fisiológicas - PIPGCF
dc.publisher.initials.fl_str_mv UFSCar
dc.publisher.country.fl_str_mv BR
publisher.none.fl_str_mv Universidade Federal de São Carlos
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFSCAR
instname:Universidade Federal de São Carlos (UFSCAR)
instacron:UFSCAR
instname_str Universidade Federal de São Carlos (UFSCAR)
instacron_str UFSCAR
institution UFSCAR
reponame_str Repositório Institucional da UFSCAR
collection Repositório Institucional da UFSCAR
bitstream.url.fl_str_mv https://repositorio.ufscar.br/bitstream/ufscar/1290/1/1710.pdf
https://repositorio.ufscar.br/bitstream/ufscar/1290/2/1710.pdf.jpg
bitstream.checksum.fl_str_mv e782712ebc5089e6011701c6a7756744
df35a859fd82baf004e5de12ff883c81
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)
repository.mail.fl_str_mv
_version_ 1813715509868232704